These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6241574)

  • 1. Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells.
    Wilson GL; Patton NJ; McCord JM; Mullins DW; Mossman BT
    Diabetologia; 1984 Dec; 27(6):587-91. PubMed ID: 6241574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro.
    Sandler S; Swenne I
    Diabetologia; 1983 Nov; 25(5):444-7. PubMed ID: 6228481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
    Uchigata Y; Yamamoto H; Kawamura A; Okamoto H
    J Biol Chem; 1982 Jun; 257(11):6084-8. PubMed ID: 6281256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
    Masiello P; Cubeddu TL; Frosina G; Bergamini E
    Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.
    Uchigata Y; Yamamoto H; Nagai H; Okamoto H
    Diabetes; 1983 Apr; 32(4):316-8. PubMed ID: 6299867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin-induced impairment of islet B-cell metabolism and its prevention by a hydroxyl radical scavenger and inhibitors of poly(ADP-ribose) synthetase.
    Sandler S; Welsh M; Andersson A
    Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):392-400. PubMed ID: 6318515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
    Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets.
    Yamamoto H; Uchigata Y; Okamoto H
    Nature; 1981 Nov; 294(5838):284-6. PubMed ID: 6272129
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential insulin secretory activity in rat pancreatic islets and HIT cells.
    Tanigawa K; Kashiwada J; Tamura K; Kawaguchi M; Seino Y; Kato Y
    Diabetes Res; 1994; 26(1):1-11. PubMed ID: 7664532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity.
    LeDoux SP; Hall CR; Forbes PM; Patton NJ; Wilson GL
    Diabetes; 1988 Aug; 37(8):1015-9. PubMed ID: 2968936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
    Bolaffi JL; Nagamatsu S; Harris J; Grodsky GM
    Endocrinology; 1987 May; 120(5):2117-22. PubMed ID: 2952491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role.
    Meghana K; Sanjeev G; Ramesh B
    Eur J Pharmacol; 2007 Dec; 577(1-3):183-91. PubMed ID: 17900558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors.
    Yamagami T; Miwa A; Takasawa S; Yamamoto H; Okamoto H
    Cancer Res; 1985 Apr; 45(4):1845-9. PubMed ID: 2983889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of poly(ADP-ribose) synthetase inhibitor administration to streptozotocin-induced diabetic rats on insulin and glucagon contents in their pancreas.
    Shima K; Hirota M; Sato M; Numoto S; Oshima I
    Diabetes Res Clin Pract; 1987; 3(3):135-42. PubMed ID: 2954803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro.
    Masiello P; Novelli M; Fierabracci V; Bergamini E
    Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):17-32. PubMed ID: 2145620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets.
    Asayama K; English D; Slonim AE; Burr IM
    Diabetes; 1984 Feb; 33(2):160-3. PubMed ID: 6229439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide does not protect islet B-cell metabolism against alloxan toxicity.
    Sandler S; Welsh M; Andersson A
    Diabetes; 1984 Oct; 33(10):937-43. PubMed ID: 6237009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
    Szkudelski T
    Physiol Res; 2001; 50(6):537-46. PubMed ID: 11829314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of HaCat keratinocytes to diabetogenic toxins.
    Harel A; Bloch O; Vardi P; Bloch K
    Biochem Pharmacol; 2002 Jan; 63(2):171-8. PubMed ID: 11841791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.